M Schmitt Selected Research

M Schmitt Research Topics

Disease

55	Neoplasms (Cancer) 01/2021 - 01/2000
28	Breast Neoplasms (Breast Cancer) 04/2021 - 01/2000
22	Neoplasm Metastasis (Metastasis) 05/2017 - 01/2000
10	Leukemia 01/2012 - 12/2000
9	Ovarian Neoplasms (Ovarian Cancer) 05/2017 - 01/2001
7	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 04/2010 - 09/2005
5	Infections 01/2020 - 07/2006
5	Squamous Cell Carcinoma of Head and Neck 12/2011 - 07/2000
3	Carcinoma (Carcinomatosis) 06/2010 - 10/2004
2	Neutropenia 12/2022 - 08/2016
2	Seizures (Absence Seizure) 09/2016 - 09/2002
2	Atherosclerosis 08/2015 - 12/2001
2	Necrosis 03/2015 - 03/2003
2	Graft vs Host Disease (Graft-Versus-Host Disease) 12/2014 - 04/2007
2	Heart Failure 01/2013 - 03/2001
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2012 - 12/2000
2	Disease Progression 01/2012 - 04/2006
2	Head and Neck Neoplasms (Head and Neck Cancer) 12/2011 - 11/2005
2	Wilms Tumor (Wilm's Tumor) 06/2011 - 10/2010
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2009 - 11/2004
2	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 03/2008 - 01/2007
2	Spinal Dysraphism (Spina Bifida) 02/2006 - 10/2001
2	Ischemia 09/2002 - 09/2001
2	Hepatoblastoma 08/2001 - 10/2000
2	Cholestasis 03/2001 - 05/2000
1	Invasive Fungal Infections 12/2022
1	Malaria 01/2020
1	Glucose Intolerance 12/2015

Drug/Important Bio-Agent (IBA)

24	AntigensIBA 12/2014 - 01/2000
22	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 05/2013 - 01/2000
19	Plasminogen Activator Inhibitor 1IBA 08/2019 - 01/2000
16	Proteins (Proteins, Gene)FDA Link 08/2019 - 01/2000
11	Peptide Hydrolases (Proteases)FDA Link 09/2013 - 06/2000
10	Plasminogen Activators (Plasminogen Activator)IBA 05/2013 - 01/2001
10	Serine Proteases (Serine Protease)IBA 04/2011 - 01/2000
8	Biomarkers (Surrogate Marker)IBA 09/2013 - 01/2000
7	Urokinase Plasminogen Activator ReceptorsIBA 11/2004 - 02/2000
7	Plasminogen InactivatorsIBA 05/2004 - 01/2000
6	Messenger RNA (mRNA)IBA 07/2006 - 01/2000
4	Hyaluronic Acid (Hyaluronan)IBA 01/2012 - 03/2009
4	EnzymesIBA 08/2011 - 10/2000
4	Peptides (Polypeptides)IBA 06/2011 - 01/2000
4	Tissue ExtractsIBA 07/2005 - 10/2000
3	AntibodiesIBA 01/2020 - 01/2000
3	Phosphotransferases (Kinase)IBA 08/2010 - 10/2000
3	Plasminogen Activator Inhibitor 2IBA 07/2005 - 02/2000
3	Biological FactorsIBA 01/2002 - 01/2000
3	CathepsinsIBA 09/2001 - 01/2000
3	Matrix Metalloproteinases (MMPs)IBA 08/2001 - 02/2001
3	PlasminogenIBA 08/2001 - 02/2000
2	Anti-Bacterial Agents (Antibiotics)IBA 12/2022 - 01/2003
2	Hormones (Hormone)IBA 08/2019 - 02/2000
2	EpitopesIBA 10/2017 - 12/2014
2	phenylalanyl- leucyl- phenylalanyl- glutaminyl- prolyl- glutaminyl- arginyl- phenylalaninamideIBA 09/2016 - 01/2012
2	LigandsIBA 01/2016 - 07/2006
2	DNA (Deoxyribonucleic Acid)IBA 08/2015 - 10/2011
2	Kallikreins (Kallikrein)IBA 09/2013 - 04/2011
2	Cisplatin (Platino)FDA LinkGeneric 09/2012 - 11/2005
2	ParaffinIBA 08/2010 - 06/2000
2	Formaldehyde (Formol)FDA Link 08/2010 - 06/2000
2	Tyrosine Kinase InhibitorsIBA 11/2009 - 10/2008
2	ErbB Receptors (EGF Receptor)IBA 11/2009 - 07/2006
2	HLA-G Antigens (HLA G)IBA 12/2008 - 01/2008
2	FibromodulinIBA 05/2008 - 07/2006
2	Tryptophan (L-Tryptophan)FDA Link 03/2008 - 01/2007
2	Serotonin (5 Hydroxytryptamine)IBA 03/2008 - 01/2007
2	SurvivinIBA 07/2006 - 12/2002
2	catumaxomabIBA 11/2005 - 10/2004
2	Epithelial Cell Adhesion MoleculeIBA 11/2005 - 10/2004
2	Neoplasm Antigens (Tumor Antigens)IBA 09/2005 - 01/2000
2	Fibrinolysin FDA Link 01/2005 - 10/2000
2	Cathepsin BIBA 11/2004 - 01/2000
2	Matrix Metalloproteinase InhibitorsIBA 08/2001 - 02/2001
2	GelatinIBA 08/2001 - 08/2001
2	Protein Isoforms (Isoforms)IBA 08/2001 - 06/2000
2	progelatinaseIBA 08/2001 - 08/2001
2	Metalloproteases (Metalloproteinases)IBA 08/2001 - 10/2000
2	Cell Surface ReceptorsIBA 07/2001 - 06/2001
2	Estrogens (Estrogen)FDA Link 02/2001 - 01/2000
2	RNA (Ribonucleic Acid)IBA 06/2000 - 06/2000
1	Chimeric Antigen ReceptorsIBA 01/2021
1	Antimalarials (Antimalarial Agents)IBA 01/2020
1	AminopeptidasesIBA 01/2020
1	Chemokine ReceptorsIBA 05/2017
1	Pilocarpine (Ocusert)FDA LinkGeneric 09/2016
1	Anticonvulsants (Antiepileptic Drugs)IBA 09/2016
1	Biosimilar PharmaceuticalsIBA 08/2016
1	Filgrastim (Neupogen)FDA Link 08/2016
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 08/2016

Therapy/Procedure

22	Therapeutics 12/2022 - 01/2000
8	Immunotherapy 06/2011 - 12/2000
6	Drug Therapy (Chemotherapy) 01/2012 - 01/2000
4	Stem Cell Transplantation 08/2016 - 04/2007
3	Adjuvant Chemotherapy 01/2008 - 01/2000
2	Radiotherapy 04/2021 - 05/2006
2	Transplantation 08/2016 - 04/2007
2	Aftercare (After-Treatment) 01/2012 - 05/2006
2	Enema (Enemas) 02/2006 - 10/2001
1	Hematopoietic Stem Cell Transplantation 10/2017
1	Cytoreduction Surgical Procedures 05/2017